• bitcoinBitcoin(BTC)$79,633.001.88%
  • ethereumEthereum(ETH)$2,389.573.19%
  • tetherTether(USDT)$1.000.04%
  • binancecoinBNB(BNB)$709.431.46%
  • rippleXRP(XRP)$1.301.79%
  • usd-coinUSDC(USDC)$1.000.03%
  • solanaSolana(SOL)$94.962.50%
  • tronTRON(TRX)$0.318251-0.33%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.051.53%
  • zcashZcash(ZEC)$1,289.870.40%
  • HyperliquidHyperliquid(HYPE)$81.86-3.57%
  • moneroMonero(XMR)$637.11-0.39%
  • dogecoinDogecoin(DOGE)$0.0757011.43%
  • USDSUSDS(USDS)$1.000.01%
  • whitebitWhiteBIT Coin(WBT)$76.892.37%
  • chainlinkChainlink(LINK)$11.382.52%
  • leo-tokenLEO Token(LEO)$9.350.33%
  • cardanoCardano(ADA)$0.1942932.29%
  • stellarStellar(XLM)$0.1638080.65%
  • bitcoin-cashBitcoin Cash(BCH)$287.575.32%
  • nearNEAR Protocol(NEAR)$3.94-1.92%
  • daiDai(DAI)$1.000.01%
  • Ethena USDeEthena USDe(USDE)$1.000.06%
  • uniswapUniswap(UNI)$7.30-1.34%
  • litecoinLitecoin(LTC)$55.180.97%
  • RainRain(RAIN)$0.005938-3.57%
  • CantonCanton(CC)$0.1004121.60%
  • avalanche-2Avalanche(AVAX)$8.63-0.38%
  • suiSui(SUI)$0.910.66%
  • USD1USD1(USD1)$1.00-0.02%
  • tether-goldTether Gold(XAUT)$4,096.351.83%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.14-3.57%
  • hedera-hashgraphHedera(HBAR)$0.0712370.75%
  • quant-networkQuant(QNT)$199.510.96%
  • Global DollarGlobal Dollar(USDG)$1.000.03%
  • shiba-inuShiba Inu(SHIB)$0.0000051.37%
  • paypal-usdPayPal USD(PYUSD)$1.000.01%
  • BittensorBittensor(TAO)$230.791.22%
  • crypto-com-chainCronos(CRO)$0.0515200.83%
  • Ripple USDRipple USD(RLUSD)$1.000.03%
  • EthenaEthena(ENA)$0.177665-1.56%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.16%
  • okbOKB(OKB)$110.372.16%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • pepePepe(PEPE)$0.000005-2.16%
  • aaveAave(AAVE)$130.46-0.43%
  • OndoOndo(ONDO)$0.397876-0.64%
  • Pump.funPump.fun(PUMP)$0.004206-2.69%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • Spiko Amundi Overnight Swap Fund (EUR)Spiko Amundi Overnight Swap Fund (EUR)(EURSAFO)$1.14-0.37%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Google Researchers Advance Diagnostic AI: AMIE Now Matches or Outperforms Primary Care Physicians Using Multimodal Reasoning with Gemini 2.0 Flash

May 4, 2025
in AI & Technology
Reading Time: 4 mins read
A A
Google Researchers Advance Diagnostic AI: AMIE Now Matches or Outperforms Primary Care Physicians Using Multimodal Reasoning with Gemini 2.0 Flash
ShareShareShareShareShare

LLMs have shown impressive promise in conducting diagnostic conversations, particularly through text-based interactions. However, their evaluation and application have largely ignored the multimodal nature of real-world clinical settings, especially in remote care delivery, where images, lab reports, and other medical data are routinely shared through messaging platforms. While systems like the Articulate Medical Intelligence Explorer (AMIE) have matched or surpassed primary care physicians in text-only consultations, this format falls short of reflecting telemedicine environments. Multimodal communication is essential in modern care, as patients often share photographs, documents, and other visual artifacts that cannot be fully conveyed through text alone. Limiting AI systems to textual inputs risks omitting critical clinical information, increasing diagnostic errors, and creating accessibility barriers for patients with lower health or digital literacy. Despite the widespread use of multimedia messaging apps in global healthcare, there has been little research into how LLMs can reason over such diverse data during diagnostic interactions.

Research in diagnostic conversational agents began with rule-based systems like MYCIN, but recent developments have focused on LLMs capable of emulating clinical reasoning. While multimodal AI systems, such as vision-language models, have demonstrated success in radiology and dermatology, integrating these capabilities into conversational diagnostics remains challenging. Effective AI-based diagnostic tools must handle the complexity of multimodal reasoning and uncertainty-driven information gathering, a step beyond merely answering isolated questions. Evaluation frameworks like OSCEs and platforms such as AgentClinic provide useful starting points, yet tailored metrics are still needed to assess performance in multimodal diagnostic contexts. Moreover, while messaging apps are increasingly used in low-resource settings for sharing clinical data, concerns about data privacy, integration with formal health systems, and policy compliance persist. 

YOU MAY ALSO LIKE

Gradium’s On-Device Phonon TTS Passes 200,000 Downloads in Two Weeks – Unite.AI

Sony Is Selling More PS5 Games But Still Struggling To Meet Console Demand

Google DeepMind and Google Research have enhanced the AMIE with multimodal capabilities for improved conversational diagnosis and management. Using Gemini 2.0 Flash, AMIE employs a state-aware dialogue framework that adapts conversation flow based on patient state and diagnostic uncertainty, allowing strategic, structured history-taking with multimodal inputs like skin images, ECGs, and documents. AMIE outperformed or matched primary care physicians in a randomized OSCE-style study with 105 scenarios and 25 patient actors across 29 of 32 clinical metrics and 7 of 9 multimodal-specific criteria, demonstrating strong diagnostic accuracy, reasoning, communication, and empathy. 

The study enhances the AMIE diagnostic system by incorporating multimodal perception and a state-aware dialogue framework that guides conversations through phases of history taking, diagnosis, and follow-up. Gemini 2.0 Flash powers the system and dynamically adapts based on evolving patient data, including text, images, and clinical documents. A structured patient profile and differential diagnosis are updated throughout the interaction, with targeted questions and multimodal data requests guiding clinical reasoning. Evaluation includes automated perception tests on isolated artifacts, simulated dialogues rated by auto-evaluators, and expert OSCE-style assessments, ensuring robust diagnostic performance and clinical realism. 

The results show that the multimodal AMIE system performs at par or better than primary care physicians (PCPs) across multiple clinical tasks in simulated text-chat consultations. In OSCE-style assessments, AMIE consistently outperformed PCPs in diagnostic accuracy, especially when interpreting multimodal data such as images and clinical documents. It also demonstrated greater robustness when image quality was poor and showed fewer hallucinations. Patient actors rated AMIE’s communication skills highly, including empathy and trust. Automated evaluations confirmed that AMIE’s advanced reasoning framework, built on the Gemini 2.0 Flash model, significantly improved diagnosis and conversation quality, validating its design and effectiveness in real-world clinical scenarios. 

In conclusion, the study advances conversational diagnostic AI by enhancing AMIE to integrate multimodal reasoning within patient dialogues. Using a novel state-aware inference-time strategy with Gemini 2.0 Flash, AMIE can interpret and reason about medical artifacts like images or ECGs in real-time clinical conversations. Evaluated through a multimodal OSCE framework, AMIE outperformed or matched primary care physicians in diagnostic accuracy, empathy, and artifact interpretation, even in complex cases. Despite limitations tied to chat-based interfaces and the need for real-world testing, these findings highlight AMIE’s potential as a robust, context-aware diagnostic assistant for future telehealth applications. 


Check out the Paper and Technical details. Also, don’t forget to follow us on Twitter and join our Telegram Channel and LinkedIn Group. Don’t Forget to join our 90k+ ML SubReddit. For Promotion and Partnerships, please talk us.

🔥 [Register Now] miniCON Virtual Conference on AGENTIC AI: FREE REGISTRATION + Certificate of Attendance + 4 Hour Short Event (May 21, 9 am- 1 pm PST) + Hands on Workshop


Sana Hassan, a consulting intern at Marktechpost and dual-degree student at IIT Madras, is passionate about applying technology and AI to address real-world challenges. With a keen interest in solving practical problems, he brings a fresh perspective to the intersection of AI and real-life solutions.

Credit: Source link

ShareTweetSendSharePin

Related Posts

Gradium’s On-Device Phonon TTS Passes 200,000 Downloads in Two Weeks – Unite.AI
AI & Technology

Gradium’s On-Device Phonon TTS Passes 200,000 Downloads in Two Weeks – Unite.AI

November 5, 2026
Sony Is Selling More PS5 Games But Still Struggling To Meet Console Demand
AI & Technology

Sony Is Selling More PS5 Games But Still Struggling To Meet Console Demand

November 5, 2026
Together AI Releases Together Compiler: Agents Make Inference Up to 2.6x Faster
AI & Technology

Together AI Releases Together Compiler: Agents Make Inference Up to 2.6x Faster

November 5, 2026
OpenAI’s Enterprise Sales Take Majority as Brockman Sees IPO Readiness – Unite.AI
AI & Technology

OpenAI’s Enterprise Sales Take Majority as Brockman Sees IPO Readiness – Unite.AI

November 5, 2026
Next Post
Wall Street Brunch: Bye Bye Buffett (NYSE:BRK.B)

Wall Street Brunch: Bye Bye Buffett (NYSE:BRK.B)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Stephen Curry breaks Luka Dončić's ankles as part of 25-point comeback in NBA Cup win – Yahoo Sports

Stephen Curry breaks Luka Dončić's ankles as part of 25-point comeback in NBA Cup win – Yahoo Sports

October 31, 2026
Macleods Pharma USA recalls thousands of blood pressure medication after pills fail quality test

Macleods Pharma USA recalls thousands of blood pressure medication after pills fail quality test

November 3, 2026
Election Edition: Will Democrats (Finally) Turn Texas Blue?

Election Edition: Will Democrats (Finally) Turn Texas Blue?

November 2, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!